Predictors of Skin Temperature, Plantar Pressure and Ulceration in Diabetic Foot Patients.

Sponsor
Universidade do Porto (Other)
Overall Status
Completed
CT.gov ID
NCT03254095
Collaborator
Centro Hospitalar do Porto (Other)
54
24.9

Study Details

Study Description

Brief Summary

Diabetes is a chronic disease with increasing prevalence worldwide with a high burden to individuals and the society and it is expected to be the 7th leading cause of death in 2030. Diabetes related complications manifest in many body parts, often in the foot, due to reduced blood flow and nerve damage, increasing the risk of ulcers and amputation. High plantar pressures during walking contribute to the development of foot ulcers and foot ulcer recurrence. Emerging studies also point skin temperature as another predictor of foot ulceration. However, the number of studies including prediction models of plantar pressure and skin temperature are scarce, especially in patients with confirmed diagnosis of diabetic foot and a history of foot ulcer. Factors like mobility, hardness of plantar soft tissue, foot deformities and other diabetes related characteristics have been related to plantar pressure measurements but not to foot skin temperature measurements, and the relation between skin temperature and plantar pressure has not been much explored in the literature. The role of these variables in the development of foot ulceration needs further attention, especially in patients with history of foot ulcers has they are at the highest risk to develop a foot ulcer.

Therefore, the goal of this research is to determine which variables can be used to predict plantar pressure and skin temperature and which factors are associated with the development of foot ulcers in patients with established diagnosis of diabetic foot. The associations between skin temperature and plantar pressure will also be addressed.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational [Patient Registry]
    Actual Enrollment :
    54 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Thermal and Biomechanical Characterization of Diabetic Foot Patients, Predictors of Skin Temperature, Barefoot Plantar Pressure and Ulceration.
    Actual Study Start Date :
    Sep 1, 2016
    Actual Primary Completion Date :
    May 31, 2017
    Actual Study Completion Date :
    Sep 30, 2018

    Outcome Measures

    Primary Outcome Measures

    1. Skin temperature [At study entry]

      After an acclimation period of 10 minutes, skin temperature of the sole and dorsum of the foot will be assessed with a thermographic camera. Thermograms will be captured before, immediately after and five minutes after a two-minute cold stress test using an aluminium plaque.

    2. Barefoot plantar pressure [At study entry]

      Barefoot plantar pressure will be assessed using a pressure platform.

    3. Percentage of patients developing a foot ulcer [One year after enrollment]

      The occurrence of foot ulceration will be assessed during a period of 1 year.

    Secondary Outcome Measures

    1. Ankle mobility [At study entry]

      Active ankle mobility (dorsiflexion and plantarflexion) will be assessed with a goniometer.

    2. Hallux active extension range of movement [At study entry]

      Hallux active extension mobility will be assessed with a goniometer.

    3. Soft tissue hardness [At study entry]

      Soft tissue hardness will be assessed with a durometer.

    4. In-shoe plantar pressure [At study entry]

      In-shoe plantar pressure will be assessed using an insole system.

    5. Time to ulceration [At study entry]

      The time to ulcer occurrence will be assessed.

    Other Outcome Measures

    1. Disease duration [At study entry]

      Diabetes duration until the assessment day will be noted.

    2. Type of diabetes [At study entry]

      The type of diabetes (Type I or Type II) will be assessed.

    3. Foot deformity [At study entry]

      The presence of claw toes, hammer toes, hallux valgus, flat foot, increased foot arch and Charcot will be assessed.

    4. Amputation [At study entry]

      The presence of minor amputation will be assessed.

    5. Neuropathy [At study entry]

      The presence of neuropathy will be assessed according to the criteria of the International Working Group on the Diabetic Foot.

    6. Peripheral artery disease [At study entry]

      Peripheral artery disease signs - an absence of foot pulses and intermittent claudication - will be assessed.

    7. Generic health status [At study entry]

      The generic health status will be assessed with the EQ-5D-5L instrument.

    8. Age [At study entry]

      The age of participants at the assessment day will be noted.

    9. Height [At study entry]

      The height of participants at the assessment day will be noted.

    10. Weight [At study entry]

      The weight of participants at the assessment day will be noted.

    11. Body mass index [At study entry]

      Body mass index will be calculated from the height and weight of the participants.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Adults (over 18 years)

    • Diagnosed as diabetic foot patient

    • Able to walk 10 meters without assistance

    Exclusion Criteria:
    • Non-cooperating patients

    • Patients with major amputations

    • Patients with a draining ulcer and/or infection

    • Patients with cognitive impairments

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Universidade do Porto
    • Centro Hospitalar do Porto

    Investigators

    • Principal Investigator: Adérito RD Seixas, MSc, Universidade do Porto

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Adérito Seixas, PhD Student, Universidade do Porto
    ClinicalTrials.gov Identifier:
    NCT03254095
    Other Study ID Numbers:
    • FADEUP_PhD_AdéritoSeixas#1
    First Posted:
    Aug 18, 2017
    Last Update Posted:
    Apr 16, 2019
    Last Verified:
    Apr 1, 2019
    Keywords provided by Adérito Seixas, PhD Student, Universidade do Porto
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 16, 2019